Thyroid medullar carcinoma. Prognostic factors;Carcinoma medular de tiroides. Factores pronósticos

Revista Clinica Espanola

Volumn 196, Issue 2, 1996, Pages 92-98

  Gavilan I ^a   Astorga, R ^b   Sasian S ^a   Acosta, D ^b   Aguilar, M ^a   Leal, A ^b   Escobar, L ^a   Cordoba J A ^a   Giron J A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Prognosis; Survival; Thyroid medullar carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MEDULLARY CARCINOMA; METASTASIS; MIDDLE AGED; MORTALITY; NEUROFIBROMATOSIS; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; SIPPLE SYNDROME; THYROID GLAND; THYROID TUMOR; TIME;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; NEOPLASM METASTASIS; PROGNOSIS; SEX FACTORS; THYROID GLAND; THYROID NEOPLASMS; TIME FACTORS;

EID: 0030079637     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Williams ED Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 1966; 19:114-118
2. Pearse AG, Carvalheira AF Cytochemical evidence for an ultimobranchial origin of rodent thyroid C cells. Nature 1967, 214:929-930.
3. McHenry CR, Oppenheim DS, Murphy T. Broughan T, Vogt D, Goldfarb WB. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity. Surgery 1992, 112:728-732.
4. Saad MF, Ordóǹez NG, Rashid RK, Guido JJ, Hill CS, Hickey RC, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognosis factors in 161 patients Medicine (Baltimore) 1984; 63:319-342
5. Grauer A, Blind E. Tumor markers for the medullary thyroid carcinoma Recent Results in cancer Research 1992; 125:55-89.
6. Saad MF, Firtsche HA, Sarnaan NA Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1984. 58:889-894.
7. Thaffer RV. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 1993; 38:1-14.
8. Mulligan LM, Kwok JBJ. Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363:458-460.
9. Lips CJM, Landsvater RM, Höppener JWM, et al Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A N Eng J Med 1994; 331:828-835.
10. Carney JA, Sizemore GW, Hayles AB. C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B Cancer 1979; 44:2.173-2.183.
11. Ghanb H. McConahey VW. Tiegs RD. Bergstralh EJ. Goellner JR. Grant CS. et al Medullary thyroid carcinoma clinicopathologic features and long-term follow-up of 65 Patients treated during 1946 through 1970 Mayo Clin Proc 1992; 67 934-940.
12. Hay ID. Ryan JJ Grants CS. Bergstralh EJ, Van Heerden JA, Goellner JR Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic an familial medullary thyroid carcinoma. Surgery 1990. 108(6) 972-980
13. Pyke CM, Hay ID. Goellner JR. Bergstralh EJ. Van Heerden JA, Grant CS Prognostic significance of calcitonin inmunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma Surgery 1991: 110 964-971.
14. Grauer A, Raue F. Gagel RF. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma Endocrinol Metab Clin North Am 1990: 19:613-635.
15. Lairmore TC. Wells SA Jr. Medullary carcinoma of the thyroid: current diagnosis and management. Semin Surg Oncol 1991; 7:92-99.
16. Ashcraft MH, Van Herle AJ. Management of thyroid nodules I: history and physical examination. blood test. X-ray test and ultrasonography. Head Neck Surg 1981; 3:216-230
17. Griffin JE. Southwestern Internal Medicine Conference. management of thyroid nodules. Am J Med Sci 1988; 296:336-347.
18. o ed). St Louis: CV Mosby, 1989, 1:391-447.
19. Garcia Poley A. Vāzquez JM. Collantes J, Escobar L, Gavilán I. García Curiel A. Características anatomoclínicas y diagnósricas del carcinoma tiroideo. Estudio de 126 casos. Revista Clinica Espan̄ola 1994: 194:3-18.
20. Nguyen TD, Chassard JL, Lagarde P, Cutuli B, Le-Fur R, Reme-Saumon M, et al. Results of postoperative radiation therapy in medullary car-cinoma of the thyroid: a retrospective study by the French Federation of Cancer institutes-The Radiotherapy Cooperative Group. Radiother Oncol 1992, 23:1-5.
21. Saad MF, Guido JJ, Samaan NA. Radioactive iodine in the treatment of medullary carcinoma of the thyroid J Clin Endocrinol Metab 1983; 57:124-129.
22. Rosai J, Carcangin ML, Delellis RA Medullary carcinoma En: Tumors of the thyroid gland, third series. Washington: Armed Forces Institute of Pathology, 1992, 207-258.
23. Hennessey JF, Wells SA, Ontjes DA, Cooper CW. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary thyroid carcinoma. J Clin Endocrinol Metab 1974; 39:487-491.
24. De Groot LJ. Thyroid carcinoma Med Clin North Am 1975; 1.233-1.238.
25. Carrasco JL. El análisis estadístico de la supervivencia. Madrid: Ed Ciencia 3, 1990
26. Minopoli MN, Bodi C. Changing patterns of sex distribution in familial medullary carcinoma of the thyroid and associated phaeochromocytoma. Clin Endocrinol (Oxf) 1983: 18:645-648.
27. Block MA, Jackson CE, Grenawald KA, You IB, Tasnjian AH Jr. Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Arch Surg 1980; 115:142-148.
28. Ziegler R. Sporadic medullary thyroid carcinoma: clinical features and diagnosis. Recent Results Cancer Res 1992; 125:91-104.
29. Rossi RL, Cady B. Meissner WA, Wool MS, Sedgwickle J. Werber J. Non-familial medullary thyroid carcinoma. Am J Surg 1980: 139:554-560.
30. Williams ED. Medullary carcinoma of the thyroid. En: de Groot LJ. Endocrinology. Hladelfia: Saunders Co., 1989; 1.132-1.164.
31. Block MA, Horn RC Jr. Miller JM, Barret JL, Brush BE. Familial medullary carcinoma of the thyroid. Ann Surg 1967; 166:403-409.
32. Chong GC, Beahrs OH, Sizemore GW, Woolner LH, Medullary carcinoma of the thyroid gland Cancer 1975; 35:695-704.
33. Sizemore GW, Carney JA, Heath H. Epidemiology of medullary carcinoma of the thyroid gland: a 5 year experience (1971-1976). Surg Clin North Am 1977: 57:633-645.
34. Torre N. Pérez A, Garcia A. Carcinoma medular de tiroides: formas de presentación, diagnóstico precoz y conducta a seguir, Endocrinología 1988; 35:152-161.
35. Rougier P, Parmentier C, Laplanche A, Lefevre H, Travagli Cailiou P. et al. Medullary thyroid carcinoma. Prognostic factors and treatment. Int J Radiol Oncol Biol Phys 1983, 9:161-169.